Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$81.24 - $97.37 $169,791 - $203,503
-2,090 Reduced 39.49%
3,202 $264,000
Q1 2024

May 14, 2024

BUY
$71.24 - $85.35 $377,002 - $451,672
5,292 New
5,292 $451,000
Q3 2023

Nov 13, 2023

BUY
$82.56 - $93.49 $271,539 - $307,488
3,289 New
3,289 $294,000
Q1 2023

May 12, 2023

BUY
$72.75 - $90.6 $56,163 - $69,943
772 New
772 $63,000
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $178,379 - $221,663
2,818 New
2,818 $209,000
Q1 2022

May 13, 2022

SELL
$43.77 - $63.22 $700,232 - $1.01 Million
-15,998 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$49.55 - $74.59 $401,057 - $603,731
-8,094 Reduced 33.6%
15,998 $849,000
Q3 2021

Nov 12, 2021

BUY
$57.6 - $70.59 $1.34 Million - $1.64 Million
23,264 Added 2809.66%
24,092 $1.7 Million
Q2 2021

Aug 13, 2021

SELL
$51.81 - $118.56 $638,765 - $1.46 Million
-12,329 Reduced 93.71%
828 $55,000
Q3 2020

Nov 13, 2020

SELL
$75.65 - $93.58 $337,247 - $417,179
-4,458 Reduced 25.31%
13,157 $1.15 Million
Q2 2020

Aug 14, 2020

BUY
$84.96 - $118.91 $1.34 Million - $1.88 Million
15,804 Added 872.67%
17,615 $1.58 Million
Q1 2020

May 14, 2020

BUY
$74.34 - $121.82 $134,629 - $220,616
1,811 New
1,811 $180,000
Q4 2019

Feb 13, 2020

SELL
$114.37 - $129.46 $265,224 - $300,217
-2,319 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$117.16 - $138.52 $7,381 - $8,726
63 Added 2.79%
2,319 $293,000
Q2 2019

Aug 14, 2019

SELL
$81.74 - $120.34 $63,430 - $93,383
-776 Reduced 25.59%
2,256 $271,000
Q1 2019

May 15, 2019

SELL
$83.25 - $102.12 $189,227 - $232,118
-2,273 Reduced 42.85%
3,032 $265,000
Q4 2018

Feb 13, 2019

BUY
$90.66 - $116.63 $208,789 - $268,598
2,303 Added 76.72%
5,305 $531,000
Q3 2018

Nov 13, 2018

BUY
$89.96 - $114.58 $270,059 - $343,969
3,002 New
3,002 $344,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.54B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.